Lexeo Therapeutics, Inc.
LXEO
Revenue
531.00k
▲531.00k∞%
-Assets
143.84M
▼-32.22M▼-18.30%
3 Months ChangeLiabilities
23.01M
▼-14.84M▼-39.20%
3 Months ChangeFree Cash Flow
-15.05M
▼-15.05M-∞%
-Revenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-05
Form 8-K
ID: 0001193125-26-039425
2026-01-27
Form 8-K
ID: 0001193125-26-023339
2026-01-12
Form 8-K
ID: 0001193125-26-010091
2025-11-05
Form 10-Q
ID: 0001193125-25-265757
2025-11-05
Form 8-K
ID: 0001193125-25-265755
2025-10-17
Form 8-K
ID: 0001193125-25-242652
2025-10-07
Form 8-K
ID: 0001193125-25-232514
2025-08-14
Form 10-Q
ID: 0000950170-25-108427
2025-08-14
Form 8-K
ID: 0000950170-25-108426
2025-06-30
Form 8-K
ID: 0000950170-25-091671